30.08.2021 - 03.09.2021Hynes Convention Center, 900 Boylston Street, 02115 Boston, Massachusetts, USA
Time: 09:00 to 17:00
Conference themes With 2 CAR-T therapies striving for global approval, and a 3rd contender from Bristol-Myers Squibb closing in on the finish line of the race to market, the CAR-TCR field continues to boom with excitement as the competition begins to heat back up.
It is well known that the current approved therapies have encountered some difficulties, specifically around their pricing and uptake in hospitals due to expensive manufacturing processes.
Speakers: Sanjay Srivastava, Accenture, Robin Goodreau, Access Biologicals, Erica Elefant, Adaptimmune, Stewart Abbott, Adicet Bio, Paul Rennert, Aleta Biotherapeutics, and more.